CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
Trump Pardon Clears Juan Orlando Hernández as U.S. Court Dismisses Drug Conviction Appeal 
Bank of America's $72.5M Epstein Settlement: What You Need to Know 
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal 
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit 
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
Trump Administration Settles Lawsuit Barring Federal Agencies from Pressuring Social Media Censorship 
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 
Trump Administration Sues Three States Over Prediction Market Regulations 
Trump and IRS in Settlement Talks Over $10 Billion Tax Return Leak Lawsuit 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch 
The Missouri Supreme Court rejected Johnson & Johnson's appeal of a ruling by the Missouri Court of Appeals awarding $2.12 billion damages to women who blamed the company's asbestos-tainted products for their ovarian cancer.
The New Brunswick, New Jersey-based firm called the verdict a product of fundamentally flawed trial, grounded in a faulty presentation of the facts and vowed to elevate the case to the US Supreme Court.
Johnson & Johnson insists that there were decades of independent scientific evaluations that found their product safe, asbestos-free, and not cancer-causing.
In July 2018, a jury ruled that Johnson & Johnson was liable $4.69 billion to the complainants.
The Missouri Court of Appeals upheld the jury verdict on June 23 but reduced the payout to $2.12 billion after dismissing claims by 22 plaintiffs.
It said that it may be inferred from evidence that the company disregarded consumer safety for profit.
Kevin Parker, a lawyer for the plaintiffs, said that Johnson & Johnson should accept the verdict of the jury and the appellate court and compensate the victims.
Johnson & Johnson said it would set aside a $2.1 billion reserve for the verdict.
The company, which said that it would stop selling its Baby Powder talc in the US and Canada, revealed that it faces over 21,800 lawsuits claiming that its talc products contain asbestos, a known carcinogen.
Johnson & Johnson's baby powder was intensely scrutinized for safety after a 2018 Reuters investigative report said that it knew for decades that about the asbestos contamination of its talc.
Evidence showed that from at least 1971 to the early 2000s,
Johnson & Johnson's raw talc and finished powders have tested positive for small amounts of asbestos.
